Latest news with #LouiseSinglehurst
Business Insider
24-05-2025
- Business
- Business Insider
Compagnie Financiere Richemont (CFRUY) Gets a Hold from Goldman Sachs
In a report released on May 22, Louise Singlehurst from Goldman Sachs initiated coverage with a Hold rating on Compagnie Financiere Richemont (CFRUY – Research Report) and a price target of $19.20. The company's shares closed yesterday at $19.07. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Singlehurst is a 3-star analyst with an average return of 0.8% and a 51.47% success rate. Singlehurst covers the Consumer Cyclical sector, focusing on stocks such as Ermenegildo Zegna, Prada SpA, and Compagnie Financiere Richemont. Currently, the analyst consensus on Compagnie Financiere Richemont is a Hold with an average price target of $19.20.
Business Insider
24-05-2025
- Business
- Business Insider
Dr. Martens Plc (DOCS) Receives a Hold from Goldman Sachs
Goldman Sachs analyst Louise Singlehurst maintained a Hold rating on Dr. Martens Plc (DOCS – Research Report) on May 21 and set a price target of p66.00. The company's shares closed today at p54.70. Confident Investing Starts Here: Singlehurst covers the Consumer Cyclical sector, focusing on stocks such as Ermenegildo Zegna, Prada SpA, and Birkenstock Holding plc. According to TipRanks, Singlehurst has an average return of 0.8% and a 51.47% success rate on recommended stocks. Dr. Martens Plc has an analyst consensus of Moderate Buy, with a price target consensus of p81.00, which is a 48.08% upside from current levels. In a report released on May 19, RBC Capital also maintained a Hold rating on the stock with a p60.00 price target. DOCS market cap is currently £535.4M and has a P/E ratio of 18.69. Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DOCS in relation to earlier this year.
